A deep dive and review of the last six months for the first half of 2024 as discussed by Steve Bell and Tom Salemi out of One60Studios.
We cover a number of areas, certainly not complete but discussions that seem to be salient to todays market:
- Last 6 months in surgical robotics
- The Impact of Intuitive DaVinci 5
- The Rise of the Smaller Robots
- What is the Definition of a Surgical Robot
- Reimbursement Drives Robotic Development
- ASC’s Influence of the Category
- The Impact and Influence of SRS 2024
- The OUS Robotics Space
- The FDA’s Approach
- Medtronic, Johnson & Johnson, Stryker and the Road Ahead
- Telesurgery and Its Place
- Endovascular Surgical Robotics
- Hard Tissue Robotics
- Closing Thoughts
Hoping you enjoy this and it provokes health, transparency, and much needed conversations for companies and careers.
